市場調查報告書
商品編碼
1518346
數位病理學市場:依產品、應用、最終用戶劃分 - 2030 年全球預測Digital Pathology Market by Offering (Hardware, Software, Service), Application (Diagnostic, Drug Discovery, Training), End User (Hospital, Academic Institute) - Global Forecast to 2030 |
數位病理市場預計到 2030 年將達到 18.6 億美元,2023 年至 2030 年複合年增長率為 8.7%。
經過廣泛的二次和初步研究以及對市場情景的詳細分析,本報告提供了關鍵行業驅動因素、限制因素和市場驅動因素/課題的分析。
這一市場成長的推動因素包括慢性病盛行率的上升、擴大採用數位病理學解決方案以提高實驗室效率以及數位病理診斷在伴隨診斷和藥物開發中的廣泛應用。然而,數位病理檢測服務缺乏報銷限制了該市場的成長。
此外,對個人化醫療的需求不斷增長、私人病理診所推出價格實惠的掃瞄儀以及新興經濟體正在為數位病理解決方案提供者創造巨大的商機。然而,數位病理學的法律和監管障礙以及缺乏訓練有素的病理學家是該市場的主要課題。
Digital Pathology Market Size, Share, Forecast, & Trends Analysis by Offering (Hardware [Scanner, Tissue Microarray], Software [Information Management, Image Analysis], Service), Application (Diagnostic, Drug Discovery), End User-Global Forecast to 2030
The digital pathology market is projected to reach $1.86 billion by 2030 at a CAGR of 8.7% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by the rising prevalence of chronic diseases, the increasing adoption of digital pathology solutions to enhance lab efficiency, and the widening applications of digital pathology in companion diagnostics and drug development. However, the lack of reimbursements for digital pathology services restrains the growth of this market.
Furthermore, the rising demand for personalized medicine, the launch of affordable scanners for private pathology practices, and developing economies are generating significant opportunities for digital pathology solutions providers. However, the legal and regulatory hurdles in digital pathology and the shortage of trained pathologists are major challenges in this market.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the digital pathology market are 3DHISTECH Ltd. (Hungary), Leica Microsystems (a subsidiary of Danaher Corporation) (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc. (U.S.).
Based on offering, in 2023, the hardware segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the increased demand for precise & accurate diagnosis and an increase in patients requiring in vitro tests.
Based on application, in 2023, the disease diagnosis segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the high burden of chronic diseases, the high adoption of teleconsulting, and rising awareness about the importance of early disease diagnosis.
Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the increased availability and affordability of advanced technological pathology solutions at hospitals, the higher preference for hospitals/clinics as a primary center for care, and the high volume of patient inflow in hospitals & clinics.
An in-depth analysis of the geographical scenario in the digital pathology market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the digital pathology market. Furthermore, in 2023, the U.S. is expected to hold the major market share in North America. Market growth in the U.S. is driven by the digitization of pathology services, high investments in R&D, the high adoption of advanced technologies, and the increased demand for reliable and faster diagnostics.
Digital Pathology Market Assessment-by Offering
Note 1: Other hardware includes clinical microscopes and accessories.
Note 2: Other software includes digital storage systems, tissue microarray software, and telepathology platforms.
Digital Pathology Market Assessment-by Application
Digital Pathology Market Assessment-by End User
Digital Pathology Market Assessment-by Geography